Pubrica

Good Publication Practice (GPP) Guidelines

Good Publication Practice (GPP) Guidelines

Good Publication Practice (GPP) guidelines are accepted standards aimed at enhancing transparency, accuracy, and ethical rigor in medical and scientific publishing. GPP is particularly important in the pharmaceutical, biotech, and healthcare research industries, where research findings may directly influence patient care and medical policy.

What Are GPP Guidelines?

GPP Guidelines (currently GPP 2022) were designed to support ethically responsible communication of industry-sponsored research. They provide a framework for having responsible communication of study results, clarifying authorship, and complying with regulatory and journal standards.

Core Principles The Four Pillars

Main Goals of GPP:

  • Promote moral authorship and contributor recognition
  • Ensure full, transparent disclosure of conflict of interest and funding sources
  • Promote clear, accurate, and complete data presentation
  • Prevent ghost writing and plagiarism
  • Comply with global publication standards (ICMJE, CONSORT, COPE)
Inaugural Issue and Content

Core Principles of GPP

The following table highlighted the core principles of GPP and what they mean in practice:

Principle Description Transparency All contributors’ affiliations and funding should be disclosed.
Accountability Only those who meet authorship requirements should appear as authors.
Integrity Data must be accurately reported, both positive and negative results.
Compliance Professional and regulatory standards, such as the ICMJE and GPP 2022 should be followed
Reproducibility Adequate details should be included to facilitate replication.
Controversies and Criticisms

Benefits of Following GPP Guidelines

Following good public practice in publishing makes it possible to:

  • Increase acceptance for manuscripts
  • Remove the chance of ethical violations or retractions
  • Gain credibility with editors of journals and readers
  • Encourage collaboration and openness in authorship
  • Maintain compliance with regulators like the FDA, EMA etc.
PubricaΓÇÖs Viewpoint

GPP-Compliant vs. Non-Compliant Writing

GPP-compliant Non-compliance
Full author contribution disclosure Ghostwritten or hidden contributors
Transparent funding source and COI statements Hidden details of conflict-of-interest
Adherence to ICMJE and CONSORT reliable source No reliable source standardization and/or ethical review
Reporting of true data in correct manner Selective conclusions or because part of the data was hidden
PubricaΓÇÖs Viewpoint

Who Should Follow GPP Guidelines?

  • GPP guidelines are important for any and all scientific and medical publishing participants.

    • Researchers & Investigators be ethical authors, fully report the research data, and provide credit to those who should be given credit.
    • Medical Writers & Editors be clear when writing support was provided, be clear and transparent, and act within the guidelines set by journals.
    • Pharma & biotech companies: Encourage responsible reporting and avoid ethical or regulatory issues.
    • Clinical Research Organizations (CROs): Make sure to provide publication-ready content based truthful verified study data.
    • Journal publishers & peer reviewers: Adhere to publication ethics, identify conflicts of interest, and ensure quality submissions.

    Adhering to GPP will rebuild trust, enhance transparency, and help improve the credibility of published research.

Conclusion

Conclusion

Following Good Publication Practice (GPP) is not just a regulatory requirement – it is an ethical, responsible, and credible commitment to the scientific communication.

Regardless of whether you are developing a clinical trial manuscript, an abstract for a conference or a systematic review, GPP will allow your academic work to be meaningful in science and society.